MedPath

中山万远新药研发有限公司

Ownership
-
Established
2014-04-16
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

4

NMPA:4

Drug Approvals

Polyvinyl Alcohol Eye Drops

Product Name
聚乙烯醇滴眼液
Approval Number
国药准字H20258060
Approval Date
Apr 9, 2025
NMPA

Sodium Hyaluronate Eye Drops

Product Name
玻璃酸钠滴眼液
Approval Number
国药准字H20247109
Approval Date
May 22, 2024
NMPA

Polyvinyl Alcohol Eye Drops

Product Name
聚乙烯醇滴眼液
Approval Number
国药准字H20233855
Approval Date
Aug 4, 2023
NMPA

Sodium Hyaluronate Eye Drops

Product Name
玻璃酸钠滴眼液
Approval Number
国药准字H20213567
Approval Date
Jun 30, 2021
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.